SUVENPHAR

Suven Pharmaceuticals, a prominent player in the Pharmaceuticals & Drugs industry, has a market capitalization of Rs 26,676.00 crore, categorizing it as a large-cap company. The stock has shown a significant performance over the past year, with a gain of 65.17%, notably outperforming the Sensex, which recorded a rise of 13.44% during the same period. However, recent trends indicate a decline in the stock's performance. Over the past day, Suven Pharmaceuticals saw a decrease of 1.36%, while the Sensex increased by 3.74%. The company has also faced challenges over the past week and month, with declines of 7.36% and 6.94%, respectively, contrasting with the Sensex's gains of 2.02% and 9.68%. In terms of longer-term performance, Suven Pharmaceuticals has achieved a remarkable 583.67% increase over the past five years, compared to the Sensex's 162.76%. Despite these achievements, current technical indicators suggest a bearish outlook in the short term, with various metrics reflecting a cautious sentiment.